Clinical trial results
Clinical trial
results
Research Sponsor: AstraZeneca
Drugs Studied: AZD8871
National Clinical Trial #: NCT02814656
Eudra CT #: 2016-000776-14
Protocol #: D6640C00003
Study Date: June 2016 to November 2016
Short Study Title: A study in healthy male volunteers to investigate
a new drug for the treatment of chronic obstructive
pulmonary disease and possibly other lung diseases
like asthma
Thank you!
As a clinical study participant, you belong to a large community of
participants around the world. You help researchers answer important
health questions and discover new medical treatments.
Thank you for taking part in this clinical study for the drug AZD8871. This
drug is being developed to treat chronic obstructive pulmonary disease,
also called COPD, and possibly other lung diseases like asthma. You and all
of the other participants helped researchers learn if AZD8871 causes any
medical problems and how it acts in the body.
AstraZeneca, the sponsor of this study, thanks you for your help and thinks
it is important for you to know the results of your study. An independent
non-profit organisation called CISCRP prepared this summary of the study
results for you with the help of a medical writing organisation. We hope
it helps you understand and feel proud of your important role in medical
research. If you have questions about the results, please speak with the
study doctors or staff at your study site.
UK 1